gilead hiv - Search News

News

FDA Approves HIV Shot That’s 99.9% Effective

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

ConsumerAffairs · 37m

FDA approves twice-yearly injection for HIV prevention

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect Efficacy With 99.9% of Pa

CNBC on MSN · 1d

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

Pharmabiz6h

Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection

Gilead Sciences’ Yeztugo receives nod; the first and only US FDA-approved HIV prevention option offering 6 months of protection: Foster City, California Friday, June 20, 2025, 1 ...

22h

US approves twice-yearly HIV jab in ‘breakthrough moment’ for fight against Aids

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

3don MSN

Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results